Corcept Therapeutics said on Monday its experimental drug in combination with chemotherapy helped delay progression of a type ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

Northwestern Medicine scientists have uncovered new details about the genetic structure of ovarian cancer stem cells, ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ...

In a study on ovarian cancer cells, researchers from Karolinska Institutet demonstrate how the tumor environment influences ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ovarian tumors and possibly other types of cancer. New magnetic ...

Nemvaleukin alfa with pembrolizumab missed the overall survival primary end point in ARTISTRY-7 for platinum-resistant ...

That means an ovarian cancer patient could receive an intravenous injection and have her tumor stop growing following one 30-minute, non-invasive magnetic field session.

Evaluation of nemvaleukin for platinum-resistant ovarian cancer will be terminated based on OS data from an interim analysis ...

A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...